Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.94 EUR 0.83%
Market Cap: 157m EUR
Have any thoughts about
Innate Pharma SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Innate Pharma SA

Current Assets 111.6m
Cash & Short-Term Investments 91.8m
Receivables 19.8m
Non-Current Assets 39.9m
Long-Term Investments 10.4m
PP&E 5.7m
Intangibles 119k
Other Non-Current Assets 23.7m
Current Liabilities 38.2m
Accounts Payable 15.9m
Short-Term Debt 10.2m
Other Current Liabilities 12.1m
Non-Current Liabilities 84.5m
Long-Term Debt 68.5m
Other Non-Current Liabilities 16m

Balance Sheet
Innate Pharma SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
150
153
176
99
152
203
137
104
84
71
Cash
150
150
176
99
0
0
0
0
0
0
Cash Equivalents
0
3
0
0
152
203
137
104
84
71
Short-Term Investments
22
0
22
17
15
16
15
16
17
22
Total Receivables
26
0
26
14
128
6
14
13
31
46
Accounts Receivables
14
0
14
0
3
3
11
1
3
15
Other Receivables
11
0
11
14
125
3
3
13
28
31
Other Current Assets
6
0
7
7
24
13
8
5
7
9
Total Current Assets
230
0
230
138
320
238
173
138
140
148
PP&E Net
9
0
9
11
10
12
12
10
9
6
Intangible Assets
9
0
9
46
85
97
46
44
2
0
Note Receivable
0
0
0
0
0
17
30
30
14
11
Long-Term Investments
0
0
0
60
35
37
39
40
35
10
Other Long-Term Assets
33
0
33
0
2
1
7
5
9
9
Total Assets
282
N/A
0
N/A
282
N/A
255
-9%
451
+77%
401
-11%
307
-23%
267
-13%
208
-22%
184
-11%
Liabilities
Accounts Payable
16
0
16
20
86
41
21
15
14
26
Accrued Liabilities
3
0
4
4
6
7
8
7
6
7
Short-Term Debt
0
0
0
0
21
21
2
7
10
8
Current Portion of Long-Term Debt
1
0
1
1
1
2
2
31
2
9
Other Current Liabilities
55
0
55
48
83
50
12
20
9
7
Total Current Liabilities
76
0
76
74
197
122
45
80
41
40
Long-Term Debt
4
0
4
5
14
17
62
47
93
76
Deferred Income Tax
0
0
0
0
2
1
7
5
9
9
Other Liabilities
115
0
115
91
72
44
37
29
11
8
Total Liabilities
195
N/A
0
N/A
195
N/A
169
-13%
284
+68%
184
-35%
151
-18%
160
+6%
154
-4%
132
-14%
Equity
Common Stock
3
0
3
3
3
4
4
4
4
4
Retained Earnings
104
0
104
152
136
156
220
272
329
336
Additional Paid In Capital
188
0
188
235
300
370
372
375
380
384
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
86
N/A
0
N/A
86
N/A
86
0%
167
+95%
217
+30%
156
-28%
107
-31%
54
-50%
52
-4%
Total Liabilities & Equity
282
N/A
0
N/A
282
N/A
255
-9%
451
+77%
401
-11%
307
-23%
267
-13%
208
-22%
184
-11%
Shares Outstanding
Common Shares Outstanding
54
0
54
54
58
79
79
80
80
81
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More